Additional information
| Active substance | Tretinoin |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Low risk when used topically |
| Lab Test | Not typically required for monitoring |
| Strength | 0.025% |
| Also known as | Retin-A |
| Blood pressure | No direct effect |
| Trade name | Retin-A, Renova, among others |
| Storage conditions | Store at controlled room temperature, protect from light |
| Chemical name | all-trans retinoic acid |
| Formula | C20H28O2 |
| Substance class | Retinoid |
| Main action | Modulates gene expression to reduce skin inflammation and promote cell turnover |
| Half-life | 0.5 to 2 hours |
| Dosage (medical) | Typically 0.02% to 0.1% creams or gels applied topically once daily at bedtime |
| Dosage (sports) | Not applicable |
| Effects | Accelerates the turnover of superficial skin cells, reduces the formation of acne, and can diminish fine wrinkles |
| Side effects | Skin irritation, redness, dryness, and increased sensitivity to sunlight |
| Use in sports | None |
| Manufacturer | Menarini Pharma |
| Packing | 1 tube/pack |
Rovamycine 3.000.000 iu Eczacibasi
Prograf 5mg Astellas Pharma
Spiriva HandiHaler 18mg Boehringer Ingelheim
Norvacs 10 mg Pfizer
Fostimon (Merional) 150 IU HMG IBSA
FUCIDIN 500 mg Abdi Ibragim 

Reviews
There are no reviews yet.